Literature DB >> 23285921

[Clinical outcomes research of use of Shenfu injection based on hospital information system].

Jing Yang1, Ruo-Qi Zhao, Yan-Ming Xie, Hu Yang, Lin Li, Yan Zhuang.   

Abstract

OBJECTIVE: To know how Shenfu injection is used in clinical practice and to provide a reference for guiding clinical use of Shenfu injection.
METHOD: Extract Shenfu injection's post-marketing re-evaluation data from the hospital information system (HIS) of 20 national grade III-A General Hospitals, use basic statistical analysis methods to analyze Shenfu injection's indications, usage and dosage, treatment course etc. in clinical practice. RESULT: In patients using Shenfu injection, the average age was 62. 15, and patients mainly concentrated in cardiovascular medicine. In clinical practice, Shenfu injection was used mainly for treatment of coronary heart disease (diagnosed as chest obstruction in traditional Chinese medicine). The treatment course mainly ranged from 3 to 7 days, and the dosage was within the limits prescribed by the instruction.
CONCLUSION: Shenfu injection was mainly used for elderly patients, and has been used according to instruction in practice almostly.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23285921

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  1 in total

1.  Effect of Shenfu injection on immune function of mice bearing Lewis lung sarcoma with chemotherapy.

Authors:  Yukun Luo; Kangning Wang; Qiang Li; Jinyi Lang
Journal:  Tumour Biol       Date:  2016-01-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.